Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomised Trial of High Dose Versus Low Dose Radioiodine, With or Without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation Following Surgery for Differentiated Thyroid Cancer [HILO]

NCT00415233 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00415233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00415233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomised Trial of High Dose Versus Low Dose Radioiodine, With or Without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation Following Surgery for Differentiated Thyroid Cancer [HILO]
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2006
Completion date
July 31, 2025
Enrollment
438 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer